AAPS 2016: Merck to Showcase Manufacturing Services and Excipients
25 Oct 2016
Lois Manton-O'Byrne, PhD
Executive Editor
Industry news
Merck, a leading science and technology company, will showcase contract manufacturing services and comprehensive portfolio of excipients at the 2016 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, November 13-17, 2016 in Denver, Colorado at booth #1142.
Merck experts will discuss how the company's newest technologies will improve productivity, lower risk, reduce cost and promote safety. Booth presentations will describe solutions for contract manufacturing and formulation.
The company will highlight the following products and services:
- Contract manufacturing including active pharmaceutical ingredient (API) development and manufacturing services for high potency APIs and antibody drug conjugates.
- Excipients for controlled release and solubility enhancement, including recent additions to the Parteck® portfolio.
Seminar:
- Revival of a Long-lost Polymer - Merck experts will present on the "revival" of polyvinyl alcohol (PVA), a polymer with an extended history in the pharmaceutical industry, for use in improving solubility of drugs using solid dispersion technology. To be held on Tuesday, November 15, 10:30am, Exhibit Hall, Room 1.
Poster Sessions:
- Prevention of dose dumping effects in PVA based matrix tablets: A case study with two APIs. (#27M1200)- Monday
- Hot melt extrusion using direct compression excipient as a plasticizer: benefit of spray dried sorbitol. (#31M0330)- Monday
- Taste optimization in solid dose: A human sensory panel study. (#24T0130)- Tuesday
- Polyvinyl alcohol based solid dispersion using hot melt extrusion technology: simple, soluble and stable for poorly water-soluble drugs. (#30T0330)- Tuesday
- Sticking: How much lubrication can we afford? (#30W0200)- Wednesday
- Supergenerics development leveraging mesoporous silica. (#26W0230)- Wednesday
- Use of amino sugar as novel plasticizer for hot melt extrusion. (#30W0330)- Wednesday
Links
Tags
Sample ManagementSample management systems include sample storage devices such as freezers and plate storers, sample environment enclosures and sample organization, retrieval and sorter systems. Useful system features include high-throughput, automation, robotic arms, automated liquid handling and associated database systems. Accessories in sample management include barcode scanners, heat sealers and tubes.Drug DeliveryDrug Delivery refers to dosage form, route of administration, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. Drug delivery is often approached via the biopharmaceutical or small molecule drug's formulation, but it may also involve medical devices or drug-device combination products. Considerations include instrumentation, software and services. Shipping / PackagingPackaging is the technology of enclosing or protecting products for distribution, storage, sale, and use and the process and production of packages. Packaging is closely linked to Shipping and the preparing of goods for transport, warehousing, logistics, sale, and end use. Within the pharmaceutical industry packaging and shipping are used for transport, storage and logistics between Contract Research Organizations (CROs), Manufacturing and Clinical Trial companies. Packaging is also critical in the final production of a pharmaceutical product before market. Development SoftwareComputational techniques used in both the chemistry and biology aspects of drug development, for data acquisition, data analysis, processing and storage. Software is used for analysis of ADME results, toxicology, clinical trials and regulatory processes. RegulatoryPharmaceutical regulations impact on all areas of drug development, manufacture and control and supply. Services are provided from the early stages of drug development and clinical trials through to dossier submission, approval and marketing. Regulatory also includes submission of analytical studies from the pharmaceutical product and safety. Scale-upScale-Up is generally defined as the process of transferring the results of the discovery phases of the drug discovery process, obtained on a laboratory scale, to the pilot plant and finally to production scale. Scale-Up uses reactors and pump systems as well as reagents, standards and buffers. Often Scale-Up is provided as a service by Contract Manufacturing Organizations (CMOs). Bioprocessing / FermentationBioprocessing is the use of biological materials to perform commercial, scientific or medical research processes. Biological materials used include cells, enzymes and organisms. Usually bioprocessing requires a batch or continuous bioreactor such as a fermentor or cell culture system. The advantages of using a reactor include high productivity, easy configuration, adjustable values and automation.BiopharmaceuticalsBiopharmaceuticals are proteins and other compounds (such as nucleic acids) produced by living organisms that have uses as therapeutics or for in vivo diagnostics. The most well known example of a biopharmaceutical product, and the first to be approved for therapeutic use, was recombinant human insulin.Antibody Drug ConjugatesDrug DiscoveryDrug discovery is the process of identifying potential new medications, involving stages such as target identification, compound screening, and preclinical development. It relies on cutting-edge technologies like high-throughput screening, artificial intelligence, and molecular modeling to accelerate the identification of drug candidates. Drug discovery plays a pivotal role in developing new therapies for diseases ranging from cancer to rare genetic disorders. Browse our peer-reviewed product directory to find the latest drug discovery technologies, compare options, check customer feedback, and get pricing directly from manufacturers.PharmaceuticalsPharmaceuticals are medicinal drugs used in healthcare to diagnose, prevent, cure and treat illnesses. Pharmaceuticals that are excreted after use appear in wastewater and can have detrimental effects on the environment.Drug DevelopmentDrug development refers to the process of bringing a new drug to market.